Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Study of SHR-A1811 and Fulvestrant in Combination With or Without HS-10352 in Locally Advanced or Metastatic Breast Cancer Patients Who Progressed After Adjuvant Therapy

NCT06788197 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT06788197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06788197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Study of SHR-A1811 and Fulvestrant in Combination With or Without HS-10352 in Locally Advanced or Metastatic Breast Cancer Patients Who Progressed After Adjuvant Therapy
Lead sponsor
Henan Cancer Hospital
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
March 31, 2029
Enrollment
52 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, locally advanced or metastatic breast cancer